Abstract
Limited availability of 229Th for clinical applications of 213Bi necessitates investigation of alternative production routes. In reactor production, 229Th is produced from neutron transmutation of 226Ra, 228Ra, 227Ac and 228Th. Irradiations of 226Ra, 228Ra, and 227Ac targets at the Oak Ridge National Laboratory High Flux Isotope Reactor result in yields of 229Th at 26 days of 74.0±7.4 MBq/g, 260±10 MBq/g, and 1200±50 MBq/g, respectively. Intermediate radionuclide yields and cross sections are also studied.
Original language | English |
---|---|
Pages (from-to) | 19-27 |
Number of pages | 9 |
Journal | Applied Radiation and Isotopes |
Volume | 114 |
DOIs | |
State | Published - Aug 1 2016 |
Funding
This research is supported by the Isotope Program, Office of Nuclear Physics of the U.S. Department of Energy. ORNL is managed by UT-Battelle, LLC, for the U.S. Department of Energy under contract DE-AC05-00OR22725 .
Keywords
- Actinium-225
- Actinium-227
- High flux isotope reactor
- Isochain
- Neutron reactions
- Radium-226
- Radium-228
- Thorium-228
- Thorium-229